Healthcare Pharmaceutical Biotech

Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer

May 19, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) announced that the first patient from the cohort of pediatric MVID patients in the pivotal MVID randomized double-blind crossover clinical trial has entered the active treatment only single-blind extension to evaluate the longer term safety and efficacy of crofelemer powder for oral solution as adjunctive treatment to parenteral support (PS) to support...

Read more

CLS Health's Dr. Barkha Chhabra Helps Child Born with Three Rare Conditions to Walk Normally

May 19, 2026 9:00 AM

Isaac was born with not one but three rare medical conditions - occurring together perhaps one in several million births and making diagnosis and treatment extraordinarily complex. A case study from Dr. Barkha Chhabra, a pediatric orthopedic surgeon with CLS Health, illustrates how a team of dedicated physicians delivered a solution, one cast, one therapy session, and one small step at a time. CLS Health, the physician-owned and physician-led...

Read more

CVS Health(R) and WGU Launch Online Pre-Pharmacy Degree Program for Future Pharmacists Nationwide

May 19, 2026 9:00 AM

Originally published on CVS Health Company Newsroom CVS Health® (NYSE: CVS) and WGU today announced a new online pre-pharmacy degree program designed to help address the national need for pharmacists through flexible, affordable education. Developed in collaboration with CVS Health, WGU's fully online Associate of Science-Health Science (ASHS), Pre-Pharmacy degree program helps CVS Health colleagues complete foundational academic prerequisites...

Read more

Europe's Hospital Cybersecurity Hot Zones and Top Cyber Vendors as EHR and EPR Attacks Shift From Data Theft to Care Disruption

May 19, 2026 8:50 AM

Black Book Research today issued a new European hospital cybersecurity advisory identifying the countries, attack surfaces, vendor categories, and evaluation standards now shaping hospital cybersecurity buying decisions across Europe. The advisory builds on Black Book's Pre-HIMSS26 Europe Copenhagen Cybersecurity Demand Pulse Survey of 284 self-identified European hospital, health system, HIT, clinical-digital, cybersecurity, procurement, risk,...

Read more

Empirical Spine Announces First Commercial LimiFlex(R) Cases at Stanford Medicine, Marking U.S. Launch of Motion-Preserving Alternative to Fusion for Degenerative Spondylolisthesis

May 19, 2026 8:30 AM

Empirical Spine announces the U.S. market introduction of the LimiFlex Dynamic Sagittal Tether™, an outpatient, motion-preserving alternative to spinal fusion following decompression. Todd Alamin, MD, Empirical Spine Co-founder, successfully performed the first two commercial implantations of the Class III dynamic stabilization device designed to treat Grade I lumbar degenerative spondylolisthesis with stenosis1, at Stanford Medicine on April...

Read more

Protagenic Therapeutics Engages Floyd Regulatory Strategic Consulting as Regulatory Affairs Advisor and Danforth Health as Strategic Operations Partner

May 19, 2026 8:15 AM

Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company developing novel peptide-based therapies for stress-related neuropsychiatric disorders, today announced two strategic engagements to support the advancement of its lead candidate, PT00114. The Company has engaged Floyd Regulatory Strategic Consulting, led by regulatory affairs veteran Dr. Eric Floyd, Ph.D., MBA, as Regulatory Affairs Advisor, and...

Read more

Black Book Research Releases State of Digital Healthcare IT 2026: Norway Market Report

May 19, 2026 7:47 AM

Black Book Research has released State of Digital Healthcare IT 2026: Norway, a new market intelligence report examining one of Europe's most digitally mature healthcare environments as Norway moves from foundational digitization to the next phase of healthcare IT optimization. Industry stakeholders can download the complimentary report at: https://blackbookmarketresearch.com/state-of-digital-healthcare-it-norway-2026 The report provides a...

Read more

Contract Complexity Is Costing You: 5 Ways to Spot Underpayments

May 19, 2026 7:00 AM

In today's healthcare environment, hospitals and health systems are under increasing pressure to protect margins while navigating complex payer contracts. Unfortunately, many organizations are leaving significant revenue on the table due to contract complexity, inadequate contract analysis, and overlooked underpayments. For hospital executives, this is more than an operational issue - it's a bottom-line risk. Without the right contract...

Read more

AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain

May 19, 2026 4:20 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that it will host a live seminar on 26 May from 14:00 to 15:00 CEST focusing on ACD137, the leading drug candidate in the TrkA-NAM pain project. The company recently published new results* for the TrkA-NAM pain project ACD137, and the purpose of the...

Read more

Spago Nanomedical Publishes the Annual Report for 2025

May 19, 2026 3:15 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical's annual report for 2025 is from today available at the company's website, https://spagonanomedical.se/investor-relations/#financial-reports For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, [email protected] Spago Nanomedical AB is a Swedish company in clinical development phase. The company´s development projects are based on...

Read more

BioNxt Advances Semaglutide ODF Program into Active Pharmaceutical Development

May 19, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that its Semaglutide oral dissolvable film ("ODF") program has entered the active pharmaceutical development phase in collaboration with German drug development partner Gen-Plus GmbH. The advancement represents a significant strategic milestone for BioNxt as the Company...

Read more

Cantargia Publishes Interim Report for The First Quarter of 2026

May 19, 2026 1:25 AM

Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced its interim report for the first quarter of 2026. "The first quarter of 2026 reflects both strong execution and important strategic progress for Cantargia. We have delivered promising early clinical data in MDS, advanced our pipeline, and taken decisive steps to position the Company for increased long-term value creation in a rapidly evolving treatment landscape.", said Hilde...

Read more

NanoViricides Announces Closing of ~$2 Million Registered Direct Offering

May 18, 2026 11:55 PM

NanoViricides, Inc. (NYSE American:NNVC) ("NanoViricides" or the "Company"), a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses and their variants cannot escape, today announced the closing of its previously announced registered direct offering (the "Offering") of 1,333,334 million shares of common stock (or pre-funded warrants in lieu thereof),...

Read more

JellyThin Reviewed: Don't Buy Anymore ACV Keto Gummies Before Reading This Jelly Thin Report First!

May 18, 2026 5:25 PM

Advertorial Disclosure: This article is an advertisement and contains affiliate links. Purchase links in this article are affiliate tracking URLs. A commission may be earned on qualifying purchases made through links in this content, at no additional cost to the reader. Affiliate relationships do not influence editorial content or the evaluation of products discussed. Disclosure is provided in accordance with FTC 16 CFR Part 255. JellyThin is a...

Read more

Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

May 18, 2026 4:05 PM

DENVER, CO / ACCESS Newswire / May 18, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May...

Read more

The Assistance Fund Opens New Program for Focal Segmental Glomerulosclerosis (FSGS)

May 18, 2026 12:50 PM

The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new financial assistance program for people living with focal segmental glomerulosclerosis (FSGS). The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, coinsurance, deductibles, health...

Read more

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering

May 18, 2026 12:15 PM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and developing life‑saving medicines across oncology, antivirals, and other key therapeutic areas, today announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the Company expected to be approximately $6.0 million, before deducting placement agent fees and other offering expenses payable by the Company. The...

Read more

Europe's Healthcare IT Market Enters the 2027 Readiness Cycle as Black Book Names 26 Top Client-Rated Vendors During HIMSS26 Week in Copenhagen

May 18, 2026 12:00 PM

Black Book Research today announced its 2026 European Healthcare IT Client Satisfaction Honors, recognizing 26 healthcare technology vendors and platforms whose strongest client-facing performance aligns with the next phase of European digital health: trusted data, cross-border interoperability, AI accountability, cybersecurity resilience, cloud modernization, enterprise imaging liquidity, analytics readiness and clinical workflow...

Read more

GLUTRONICS(TM) Appoints Brad Boruk as Co-Chief Executive Officer

May 18, 2026 9:55 AM

GLUTRONICS™, a medical technology startup focused on non-invasive glucose monitoring, today announced the appointment of Brad Boruk as Co-Chief Executive Officer. Boruk will serve alongside Co-CEO Dr. Hoon Kim, who continues to lead the company's technology development and research initiatives. The appointment reflects the company's intent to expand its commercial and strategic capabilities as it advances its technology toward potential future...

Read more

CVS Health: A Second Chance at Life Through Heart Transplant and Ongoing Care

May 18, 2026 9:00 AM

Originally published on CVS Health Company Newsroom Key points After smoking for decades and surviving two heart attacks, Bill Allison learned that he needed a heart transplant - and that making immediate, lasting life changes was essential. Beyond dispensing medications, Bill's CVS Specialty pharmacist, Amy Guard, has supported him throughout his post transplant journey with ongoing medication counseling and encouragement. "Listen to your...

Read more